1. Better access to, and use of, surveillance data
26th September 2016
Better access to, and use of, surveillance data
Insert name of presentation on Master Slide
Presenter: Robin Howe Chair T&F group 4

3. Total antibacterial usage by hospital: DDD/1000 BD (2015)
Insert name of presentation on Master Slide

4. Aims for T&FG4 Information for Action
Develop web access tool for availability of timely local antimicrobial resistance and usage information
Requires reliable and timely feeds of usage data from NWIS
Develop mechanisms to enable early detection of threats at local level.
ICNet
Resistance alert system
Develop web tools to support annual and local point prevalence surveys.
BSAC system (MS IE 9)
Robin Howe - T&F group 4

5. Aims for T&FG4 Information for Action
Develop infrastructure to facilitate timely local information on antimicrobial usage.
Audit+
e-Prescribing
Develop health board reports that integrate antibiotic usage and resistance data to inform areas for action.
Develop targeted surveillance of carbapenemase-producing bacteria.
Integrate resistance alerts with laboratory testing
Robin Howe - T&F group 4

6. Aims for T&FG4 Measuring success
Baseline and trends in resistance for key Drug/Bug combinations
Available through DataStore
Measuring the 50% reduction of inappropriate prescribing
Link Prescribing with indication
Primary care - Audit+
Secondary care - e-Prescribing, audit, PPS
Measuring the 50% reduction in HA-GNBacteraemia
Develop within ICNet
Measuring “lack of harm”
Robin Howe - T&F group 4

7. Engagement Public Health Wales NWIS AWMSG Chief Pharmacist Group
AWTTC
AWPAG
Chief Pharmacist Group
AWAPG
Health Boards & Trusts
Robin Howe - T&F group 4